Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar J Rolleman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginineEdgar J Rolleman, Roelf Valkema, Marion de Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructoseEdgar J Rolleman, Eric P Krenning, Arthur Van Gameren, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2009
Kidney protection during peptide receptor radionuclide therapy with somatostatin analoguesEdgar J Rolleman, Marleen Melis, Roelf Valkema, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2007
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidneyEdgar J Rolleman, Peter P M Kooij, Wouter W de Herder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2006
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotateEdgar J Rolleman, Flavio Forrer, Bert Bernard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2009
Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumoursMarleen Melis, Magda Bijster, Monique de Visser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2006
Long-term toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in ratsEdgar J Rolleman, Eric P Krenning, Bert F Bernard, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginineEdgar J Rolleman, Roelf Valkema, Marion de Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructoseEdgar J Rolleman, Eric P Krenning, Arthur Van Gameren, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2009
Kidney protection during peptide receptor radionuclide therapy with somatostatin analoguesEdgar J Rolleman, Marleen Melis, Roelf Valkema, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2007
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidneyEdgar J Rolleman, Peter P M Kooij, Wouter W de Herder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2006
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotateEdgar J Rolleman, Flavio Forrer, Bert Bernard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2009
Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumoursMarleen Melis, Magda Bijster, Monique de Visser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2006
Long-term toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in ratsEdgar J Rolleman, Eric P Krenning, Bert F Bernard, et al.
Pageof 1